Artivion Inc.

17.74+0.1400+0.80%Vol 220.98K1Y Perf 37.61%
Nov 30th, 2023 16:00 DELAYED
BID17.02 ASK17.90
Open17.76 Previous Close17.74
Pre-Market- After-Market17.90
 - -  0.16 0.90%
Target Price
23.13 
Analyst Rating
Strong Buy 1.20
Potential %
30.38 
Finscreener Ranking
★★★+     50.85
Insiders Trans % 3/6/12 mo.
-/-100/-56 
Value Ranking
★★★+     52.85
Insiders Value % 3/6/12 mo.
-/-100/-57 
Growth Ranking
     38.34
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-54 
Income Ranking
 —    -
Price Range Ratio 52W %
96.50 
Earnings Rating
Market Cap728.20M 
Earnings Date
2nd Nov 2023
Alpha-0.02 Standard Deviation0.13
Beta1.41 

Today's Price Range

17.4717.87

52W Range

11.3917.97

5 Year PE Ratio Range

-259.50684.30

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
0.45%
1 Month
37.73%
3 Months
1.90%
6 Months
20.11%
1 Year
37.61%
3 Years
-15.24%
5 Years
-41.49%
10 Years
60.54%

TickerPriceChg.Chg.%
AORT17.740.14000.80
AAPL189.910.54000.29
GOOG133.91-2.4900-1.83
MSFT378.73-0.1200-0.03
XOM102.740.40000.39
WFC44.590.81001.85
JNJ154.662.55001.68
FB196.640.99000.51
GE121.802.94002.47
JPM156.081.76001.14
Financial StrengthValueIndustryS&P 500US Markets
2.20
5.20
0.58
1.39
-1.10
Leverage Ratio 2.80
ProfitabilityValueIndustryS&P 500US Markets
64.70
-5.60
1.70
-5.40
-9.11
RevenueValueIndustryS&P 500US Markets
234.39M
5.81
3.00
9.55
Earnings HistoryEstimateReportedSurprise %
Q03 20230.010.02100.00
Q02 20230.010.06500.00
Q01 2023-0.030.02166.67
Q04 2022-0.170.10158.82
Q03 2022-0.11-0.0554.55
Q02 20220.04-0.03-175.00
Q01 20220.000.03-
Q04 2021-0.110.00100.00
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report0.01
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume220.98K
Shares Outstanding41.05K
Shares Float38.34M
Trades Count3.65K
Dollar Volume3.91M
Avg. Volume248.43K
Avg. Weekly Volume283.29K
Avg. Monthly Volume240.68K
Avg. Quarterly Volume221.31K

Artivion Inc. (NYSE: AORT) stock closed at 17.74 per share at the end of the most recent trading day (a 0.8% change compared to the prior day closing price) with a volume of 220.98K shares and market capitalization of 728.19M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 1200 people. Artivion Inc. CEO is James Patrick Mackin.

The one-year performance of Artivion Inc. stock is 37.61%, while year-to-date (YTD) performance is 46.37%. AORT stock has a five-year performance of -41.49%. Its 52-week range is between 11.39 and 17.97, which gives AORT stock a 52-week price range ratio of 96.50%

Artivion Inc. currently has a PE ratio of -12.00, a price-to-book (PB) ratio of 1.97, a price-to-sale (PS) ratio of 2.13, a price to cashflow ratio of 324.40, a PEG ratio of -, a ROA of -5.74%, a ROC of -4.88% and a ROE of -15.88%. The company’s profit margin is -9.11%, its EBITDA margin is 1.70%, and its revenue ttm is $234.39 Million , which makes it $5.81 revenue per share.

Of the last four earnings reports from Artivion Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.01 for the next earnings report. Artivion Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Artivion Inc. is Strong Buy (1.2), with a target price of $23.13, which is +30.38% compared to the current price. The earnings rating for Artivion Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Artivion Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Artivion Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 41.65, ATR14 : 0.74, CCI20 : 118.27, Chaikin Money Flow : 0.03, MACD : 1.00, Money Flow Index : 77.94, ROC : 33.08, RSI : 73.30, STOCH (14,3) : 96.82, STOCH RSI : 0.64, UO : 62.80, Williams %R : -3.18), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Artivion Inc. in the last 12-months were: Amy D. Horton (Option Excercise at a value of $212 101), Amy D. Horton (Sold 22 645 shares of value $315 694 ), Andrew M. Green (Sold 1 747 shares of value $22 603 ), D. Ashley Lee (Option Excercise at a value of $377 057), D. Ashley Lee (Sold 36 395 shares of value $480 542 ), David Ashley Lee (Option Excercise at a value of $377 057), David Ashley Lee (Sold 34 994 shares of value $461 904 ), Dennis B Maier (Sold 2 330 shares of value $30 146 ), Getz Matthew (Sold 8 631 shares of value $130 622 ), Green Andrew (Sold 2 572 shares of value $33 669 ), Horton Amy (Option Excercise at a value of $212 101), Horton Amy (Sold 20 121 shares of value $281 366 ), James P. Mackin (Option Excercise at a value of $671 222), James P. Mackin (Sold 89 120 shares of value $1 173 728 ), James Patrick Mackin (Option Excercise at a value of $671 222), James Patrick Mackin (Sold 79 130 shares of value $1 039 994 ), Jean F. Holloway (Sold 2 867 shares of value $37 521 ), John E. Davis (Option Excercise at a value of $89 549), John E. Davis (Sold 3 514 shares of value $45 993 ), Maier Dennis (Sold 19 705 shares of value $293 408 ), Maney Rochelle (Sold 2 105 shares of value $27 746 ), Marshall S. Stanton (Sold 2 337 shares of value $30 236 ), Matthew A. Getz (Sold 1 600 shares of value $20 701 ), Rochelle L. Maney (Sold 1 284 shares of value $16 733 ), Stanton Marshall (Sold 3 244 shares of value $42 404 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.20
Strong Buy
1.20
Strong Buy
1.20

Artivion Inc.

Cryolife Inc is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair. The company has two reportable segments namely Medical devices and Preservation Services. The Medical Devices segment includes revenues from sales of BioGlue, On-X products, JOTEC products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular tissues. It generates a majority of its revenue from the Medical Devices segment. Geographically, the company generates a majority of its revenue from the United States.

CEO: James Patrick Mackin

Telephone: +1 770 419-3355

Address: 1655 Roberts Boulevard North West, Kennesaw 30144, GA, US

Number of employees: 1 200

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

57%43%

Bearish Bullish

56%44%

 

News

Stocktwits